Partial pancreatic head resection for pancreatic metastasis from renal cell carcinoma.
Is radical resection of hilar cholangiocarcinoma plus partial resection of pancreatic head justified for advanced hilar cholangiocarcinoma?
[Limited chronic inflammation of the pancreatic head treated by means of partial resection].
Reporting of longitudinal pancreatojejunostomy with partial pancreatic head resection (the Frey procedure) for chronic pancreatitis: A systematic review.
Baltatzis M, Jegatheeswaran S, Siriwardena AK.
Hepatobiliary Pancreat Dis Int. 2021 Apr;20(2):110-116. doi: 10.1016/j.hbpd.2021.02.004. Epub 2021 Feb 13.
Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors-a Systematic Review and Meta-analysis of Surgery-Associated Morbidity.
Beger HG, Mayer B, Poch B.
J Gastrointest Surg. 2023 Nov;27(11):2611-2627. doi: 10.1007/s11605-023-05789-4. Epub 2023 Sep 5.
Duodenum-preserving total and partial pancreatic head resection for benign tumors--systematic review and meta-analysis.
Beger HG, Nakao A, Mayer B, Poch B.
Pancreatology. 2015 Mar-Apr;15(2):167-78. doi: 10.1016/j.pan.2015.01.009. Epub 2015 Feb 7.
Is radical resection of hilar cholangiocarcinoma plus partial resection of pancreatic head justified for advanced hilar cholangiocarcinoma?
Liu F, Hu HJ, Ma WJ, Wang JK, Ran CD, Regmi P, Li FY.
ANZ J Surg. 2020 Sep;90(9):1666-1670. doi: 10.1111/ans.15955. Epub 2020 May 25.
[Duodenum-preserving pancreatic head resection in chronic pancreatitis : Limitations of the Heidelberg multicenter ChroPac study].
Beger HG, Mayer B.
Chirurg. 2018 May;89(5):392-396. doi: 10.1007/s00104-018-0615-4.
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.
Ghaneh P, Palmer D, Cicconi S, Jackson R, Halloran CM, Rawcliffe C, Sripadam R, Mukherjee S, Soonawalla Z, Wadsley J, Al-Mukhtar A, Dickson E, Graham J, Jiao L, Wasan HS, Tait IS, Prachalias A, Ross P, Valle JW, O'Reilly DA, Al-Sarireh B, Gwynne S, Ahmed I, Connolly K, Yim KL, Cunningham D, Armstrong T, Archer C, Roberts K, Ma YT, Springfeld C, Tjaden C, Hackert T, Büchler MW, Neoptolemos JP; European Study Group for Pancreatic Cancer.
Lancet Gastroenterol Hepatol. 2023 Feb;8(2):157-168. doi: 10.1016/S2468-1253(22)00348-X. Epub 2022 Dec 12.
Parenchyma-Sparing, Limited Pancreatic Head Resection for Benign Tumors and Low-Risk Periampullary Cancer--a Systematic Review.
Beger HG, Mayer B, Rau BM.
J Gastrointest Surg. 2016 Jan;20(1):206-17. doi: 10.1007/s11605-015-2981-2. Epub 2015 Nov 2.
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial.
Diener MK, Hüttner FJ, Kieser M, Knebel P, Dörr-Harim C, Distler M, Grützmann R, Wittel UA, Schirren R, Hau HM, Kleespies A, Heidecke CD, Tomazic A, Halloran CM, Wilhelm TJ, Bahra M, Beckurts T, Börner T, Glanemann M, Steger U, Treitschke F, Staib L, Thelen K, Bruckner T, Mihaljevic AL, Werner J, Ulrich A, Hackert T, Büchler MW; ChroPac Trial Group.
Lancet. 2017 Sep 9;390(10099):1027-1037. doi: 10.1016/S0140-6736(17)31960-8.
Conventional partial pancreatoduodenectomy versus an extended pancreatoduodenectomy (triangle operation) for pancreatic head cancers-study protocol for the randomised controlled TRIANGLE trial.
Heger P, Hackert T, Diener MK, Feißt M, Klose C, Dörr-Harim C, Möhlenbrock F, Büchler MW, Mihaljevic AL.
Trials. 2023 May 30;24(1):363. doi: 10.1186/s13063-023-07337-6.
Partial pancreatic resection along the embryological fusion plane - no longer a fantasy.
Łącka M, Łaski D, Hać S, Szymański M.
Folia Morphol (Warsz). 2019 Nov 21. doi: 10.5603/FM.a2019.0121. Online ahead of print.
